Home › Compare › MDBIF vs JNJ

MDBIF vs JNJ: Dividend Comparison 2026

MDBIF yields 80000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDBIF wins by $5.2077213163602945e+25M in total portfolio value
10 years
MDBIF
MDBIF
● Live price
80000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.2077213163602945e+25M
Annual income
$51,949,472,569,259,090,000,000,000,000,000.00
Full MDBIF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MDBIF vs JNJ

📍 MDBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDBIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDBIF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDBIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDBIF
Annual income on $10K today (after 15% tax)
$6,800,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,157,051,683,870,220,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MDBIF beats the other by $44,157,051,683,870,220,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDBIF + JNJ for your $10,000?

MDBIF: 50%JNJ: 50%
100% JNJ50/50100% MDBIF
Portfolio after 10yr
$2.6038606581801473e+25M
Annual income
$25,974,736,284,629,546,000,000,000,000,000.00/yr
Blended yield
99.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MDBIF
No analyst data
Altman Z
-4.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDBIF buys
0
JNJ buys
0
No recent congressional trades found for MDBIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDBIFJNJ
Forward yield80000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$5.2077213163602945e+25M$20.0K ✓
Annual income after 10y$51,949,472,569,259,090,000,000,000,000,000.00 ✓$827.78
Total dividends collected$5.206883835920424e+25M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MDBIF vs JNJ ($10,000, DRIP)

YearMDBIF PortfolioMDBIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$8,010,700$8,000,000.00$10,676$355.77+$8.00M → MDBIF
2$5,997,879,860$5,989,308,411.21$11,407$389.39+$5997.87M → MDBIF
3$4,197,442,177,404$4,191,024,445,953.32$12,198$426.53+$4197442.17M → MDBIF
4$2,745,581,773,359,261$2,741,090,510,229,439.00$13,056$467.62+$2745581773.35M → MDBIF
5$1,678,610,723,842,080,800$1,675,672,951,344,586,500.00$13,987$513.12+$1678610723842.07M → MDBIF
6$959,257,110,940,495,000,000$957,460,997,465,984,000,000.00$14,998$563.56+$959257110940495.00M → MDBIF
7$512,381,218,321,420,100,000,000$511,354,813,212,713,760,000,000.00$16,098$619.52+$512381218321420096.00M → MDBIF
8$255,816,465,068,545,120,000,000,000$255,268,217,164,941,240,000,000,000.00$17,295$681.69+$255816465068545114112.00M → MDBIF
9$119,383,733,031,653,200,000,000,000,000$119,110,009,414,029,840,000,000,000,000.00$18,599$750.82+$1.193837330316532e+23M → MDBIF
10$52,077,213,163,602,950,000,000,000,000,000$51,949,472,569,259,090,000,000,000,000,000.00$20,022$827.78+$5.2077213163602945e+25M → MDBIF

MDBIF vs JNJ: Complete Analysis 2026

MDBIF — Stock

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Full MDBIF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MDBIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDBIF vs SCHDMDBIF vs JEPIMDBIF vs OMDBIF vs KOMDBIF vs MAINMDBIF vs ABBVMDBIF vs MRKMDBIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.